From identification to characterization of the multiple sclerosis susceptibility gene CLEC16A

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 4476-4497

  Berge, Tone ^a,b   Leikfoss, Ingvild Sørum ^a,b   Harbo, Hanne F ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoimmunity; CIITA; CLEC16A; DEXI; Multiple sclerosis; SOCS1

Indexed keywords

C TYPE LECTIN LIKE DOMAIN FAMILY 16A; LECTIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; C TYPE LECTIN LIKE DOMAIN; C TYPE LECTIN LIKE DOMAIN FAMILY 16A GENE; COMPLEX FORMATION; DEXAMETHASONE INDUCED GENE; DISEASE PREDISPOSITION; FPL DOMAIN; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II TRANSACTIVATOR GENE; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR OF CYTOKINE SIGNALING 1 GENE; TRANSMEMBRANE DOMAIN;

EID: 84875065330     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14034476     Document Type: Review

References (114)

1. Giovannoni, G.; Southam, E.; Waubant, E. Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: Tolerability and adherence. Mult. Scler. 2012, 18, 932-946.
2. Taylor, B.V.; Pearson, J.F.; Clarke, G.; Mason, D.F.; Abernethy, D.A.; Willoughby, E.; Sabel, C. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult. Scler. 2010, 16, 1422-1431.
3. Simpson, S., Jr.; Blizzard, L.; Otahal, P.; van der Mei, I.; Taylor, B. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J. Neurol. Neurosurg. Psychiatry 2011, 82, 1132-1141.
4. Alonso, A.; Hernan, M.A. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 2008, 71, 129-135.
5. O'Gorman, C.; Lucas, R.; Taylor, B. Environmental risk factors for multiple sclerosis: A review with a focus on molecular mechanisms. Int. J. Mol. Sci. 2012, 13, 11718-11752.
6. Kemppinen, A.; Sawcer, S.; Compston, A. Genome-wide association studies in multiple sclerosis: Lessons and future prospects. Brief. Funct. Genomics 2011, 10, 61-70.
7. Gourraud, P.A.; Harbo, H.F.; Hauser, S.L.; Baranzini, S.E. The genetics of multiple sclerosis: An up-to-date review. Immunol. Rev. 2012, 248, 87-103.
8. Jersild, C.; Svejgaard, A.; Fog, T. HL-A antigens and multiple sclerosis. Lancet 1972, 1, 1240-1241.
9. Olerup, O.; Zetterquist, H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: A sensitive, specific and rapid technique. Tissue Antigens 1991, 37, 197-204.
10. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; Sawcer, S.; Hellenthal, G.; Pirinen, M.; Spencer, C.C.; Patsopoulos, N.A.; Moutsianas, L.; Dilthey, A.; Su, Z, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476, 214-219.
11. Brynedal, B.; Duvefelt, K.; Jonasdottir, G.; Roos, I.M.; Akesson, E.; Palmgren, J.; Hillert, J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2007, 2, e664.
12. Fogdell-Hahn, A.; Ligers, A.; Gronning, M.; Hillert, J.; Olerup, O. Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000, 55, 140-148.
13. Mero, I.-L.; Gustavsen, M.W.; Sæther, H.S.; Flåm, S.T.; Berg-Hansen, P.; Søndergaard, H.B.; Jensen, P.E.H.; Berge, T.; Bjølgerud, A.; Muggerud, A, et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One submitted for publication, 2012.
14. International Multiple Sclerosis Genetics Consortium; Hafler, D.A.; Compston, A.; Sawcer, S.; Lander, E.S.; Daly, M.J.; de Jager, P.L.; de Bakker, P.I.; Gabriel, S.B.; Mirel, D.B, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357, 851-862.
15. Gregory, S.G.; Schmidt, S.; Seth, P.; Oksenberg, J.R.; Hart, J.; Prokop, A.; Caillier, S.J.; Ban, M.; Goris, A.; Barcellos, L.F, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007, 39, 1083-1091.
16. Lundmark, F.; Duvefelt, K.; Iacobaeus, E.; Kockum, I.; Wallstrom, E.; Khademi, M.; Oturai, A.; Ryder, L.P.; Saarela, J.; Harbo, H.F, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 2007, 39, 1108-1113.
17. Australia and New Zealand Multiple Sclerosis Genetics Consortium; Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41, 824-828.
18. Jakkula, E.; Leppa, V.; Sulonen, A.M.; Varilo, T.; Kallio, S.; Kemppinen, A.; Purcell, S.; Koivisto, K.; Tienari, P.; Sumelahti, M.L, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 2010, 86, 285-291.
19. Sanna, S.; Pitzalis, M.; Zoledziewska, M.; Zara, I.; Sidore, C.; Murru, R.; Whalen, M.B.; Busonero, F.; Maschio, A.; Costa, G, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat. Genet. 2010, 42, 495-497.
20. Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Muller-Sarnowski, F.; Pfister, H.; Roeske, D.; Rieckmann, P.; Hemmer, B, et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J. Neuroimmunol. 2010, 227, 162-166.
21. Briggs, F.B.; Bartlett, S.E.; Goldstein, B.A.; Wang, J.; McCauley, J.L.; Zuvich, R.L.; de Jager, P.L.; Rioux, J.D.; Ivinson, A.J.; Compston, A, et al. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. Hum. Mol. Genet. 2010, 19, 4286-4295.
22. De Jager, P.L.; Baecher-Allan, C.; Maier, L.M.; Arthur, A.T.; Ottoboni, L.; Barcellos, L.; McCauley, J.L.; Sawcer, S.; Goris, A.; Saarela, J, et al. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2009, 106, 5264-5269.
23. De Jager, P.L.; Jia, X.; Wang, J.; de Bakker, P.I.; Ottoboni, L.; Aggarwal, N.T.; Piccio, L.; Raychaudhuri, S.; Tran, D.; Aubin, C, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41, 776-782.
24. Baranzini, S.E.; Wang, J.; Gibson, R.A.; Galwey, N.; Naegelin, Y.; Barkhof, F.; Radue, E.W.; Lindberg, R.L.; Uitdehaag, B.M.; Johnson, M.R, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 2009, 18, 767-778.
25. Comabella, M.; Craig, D.W.; Camina-Tato, M.; Morcillo, C.; Lopez, C.; Navarro, A.; Rio, J.; Biomarker, M.S.S.G.; Montalban, X.; Martin, R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008, 3, e3490.
26. Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium; Burton, P.R.; Clayton, D.G.; Cardon, L.R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D.P.; McCarthy, M.I, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 2007, 39, 1329-1337.
27. Patsopoulos, N.A.; Bayer Pharma MS Genetics Working Group; Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist; ANZgene Consortium; GeneMSA; International Multiple Sclerosis Genetics Consortium; Esposito, F.; Reischl, J.; Lehr, S.; Bauer, D, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 2011, 70, 897-912.
28. Qiu, Z.X.; Zhang, K.; Qiu, X.S.; Zhou, M.; Li, W.M. CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis. Hum. Immunol. 2012, 74, 249-255
29. Hoppenbrouwers, I.A.; Aulchenko, Y.S.; Janssens, A.C.; Ramagopalan, S.V.; Broer, L.; Kayser, M.; Ebers, G.C.; Oostra, B.A.; van Duijn, C.M.; Hintzen, R.Q. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J. Hum. Genet. 2009, 54, 676-680.
30. Rubio, J.P.; Stankovich, J.; Field, J.; Tubridy, N.; Marriott, M.; Chapman, C.; Bahlo, M.; Perera, D.; Johnson, L.J.; Tait, B.D, et al. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 2008, 9, 624-630.
31. International Multiple Sclerosis Genetics Consortium. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 2009, 10, 11-14.
32. Mero, I.L.; Ban, M.; Lorentzen, A.R.; Smestad, C.; Celius, E.G.; Saether, H.; Saeedi, H.; Viken, M.K.; Skinningsrud, B.; Undlien, D.E, et al. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun. 2011, 12, 191-198.
33. Zoledziewska, M.; Costa, G.; Pitzalis, M.; Cocco, E.; Melis, C.; Moi, L.; Zavattari, P.; Murru, R.; Lampis, R.; Morelli, L, et al. Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun. 2009, 10, 15-17.
34. Perera, D.; Stankovich, J.; Butzkueven, H.; Taylor, B.V.; Foote, S.J.; Kilpatrick, T.J.; Rubio, J.P. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. J. Neuroimmunol. 2009, 211, 105-109.
35. Martinez, A.; Perdigones, N.; Cenit, M.C.; Espino, L.; Varade, J.; Lamas, J.R.; Santiago, J.L.; Fernandez-Arquero, M.; de la Calle, H.; Arroyo, R, et al. Chromosomal region 16p13: Further evidence of increased predisposition to immune diseases. Ann. Rheum. Dis. 2010, 69, 309-311.
36. D'Netto, M.J.; Ward, H.; Morrison, K.M.; Ramagopalan, S.V.; Dyment, D.A.; DeLuca, G.C.; Handunnetthi, L.; Sadovnick, A.D.; Ebers, G.C. Risk alleles for multiple sclerosis in multiplex families. Neurology 2009, 72, 1984-1988.
37. Johnson, B.A.; Wang, J.; Taylor, E.M.; Caillier, S.J.; Herbert, J.; Khan, O.A.; Cross, A.H.; de Jager, P.L.; Gourraud, P.A.; Cree, B.C, et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010, 11, 343-350.
38. BioGPS Gene Annotation Portal. Available online: http://biogps.org (accessed on 15 December 2012).
39. National Center for Biotechnology Information, reference sequence NM_015226.2 (Homo sapiens C-type lectin domain family 16, member A (CLEC16A)). Available online: http://www.ncbi.nlm.nih.gov/nuccore/NM_015226.2 (accessed on 15 December 2012).
40. Hakonarson, H.; Grant, S.F.; Bradfield, J.P.; Marchand, L.; Kim, C.E.; Glessner, J.T.; Grabs, R.; Casalunovo, T.; Taback, S.P.; Frackelton, E.C, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448, 591-594.
41. Skinningsrud, B.; Husebye, E.S.; Pearce, S.H.; McDonald, D.O.; Brandal, K.; Wolff, A.B.; Lovas, K.; Egeland, T.; Undlien, D.E. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 2008, 93, 3310-3317.
42. Marquez, A.; Varade, J.; Robledo, G.; Martinez, A.; Mendoza, J.L.; Taxonera, C.; Fernandez-Arquero, M.; Diaz-Rubio, M.; Gomez-Garcia, M.; Lopez-Nevot, M.A, et al. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur. J. Hum. Genet. 2009, 17, 1304-1308.
43. Hirschfield, G.M.; Xie, G.; Lu, E.; Sun, Y.; Juran, B.D.; Chellappa, V.; Coltescu, C.; Mason, A.L.; Milkiewicz, P.; Myers, R.P, et al. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun. 2012, 13, 328-335.
44. Skinningsrud, B.; Lie, B.A.; Husebye, E.S.; Kvien, T.K.; Forre, O.; Flato, B.; Stormyr, A.; Joner, G.; Njolstad, P.R.; Egeland, T, et al. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69, 1471-1474.
45. Jagielska, D.; Redler, S.; Brockschmidt, F.F.; Herold, C.; Pasternack, S.M.; Garcia Bartels, N.; Hanneken, S.; Eigelshoven, S.; Refke, M.; Barth, S, et al. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J. Invest. Dermatol. 2012, 132, 2192-2197.
46. Barrett, J.C.; Fry, B.; Maller, J.; Daly, M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21, 263-265.
47. Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Muller-Sarnowski, F.; Pfister, H.; Rieckmann, P.; Hemmer, B.; Ising, M, et al. More CLEC16A gene variants associated with multiple sclerosis. Acta Neurol. Scand. 2011, 123, 400-406.
48. Pandit, L.; Ban, M.; Sawcer, S.; Singhal, B.; Nair, S.; Radhakrishnan, K.; Shetty, R.; Misri, Z.; Hegde, S.; Bhat, I.G. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult. Scler. 2011, 17, 139-143.
49. Zuvich, R.L.; Bush, W.S.; McCauley, J.L.; Beecham, A.H.; De Jager, P.L.; Ivinson, A.J.; Compston, A.; Hafler, D.A.; Hauser, S.L.; Sawcer, S.J, et al. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: Independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Hum. Mol. Genet. 2011, 20, 3517-3524.
50. Todd, J.A.; Walker, N.M.; Cooper, J.D.; Smyth, D.J.; Downes, K.; Plagnol, V.; Bailey, R.; Nejentsev, S.; Field, S.F.; Payne, F, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39, 857-864.
51. Awata, T.; Kawasaki, E.; Tanaka, S.; Ikegami, H.; Maruyama, T.; Shimada, A.; Nakanishi, K.; Kobayashi, T.; Iizuka, H.; Uga, M, et al. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J. Clin. Endocrinol. Metab. 2009, 94, 231-235.
52. Wu, X.; Zhu, X.; Wang, X.; Ma, J.; Zhu, S.; Li, J.; Liu, Y. Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin. Endocrinol. 2009, 71, 46-49.
53. Sang, Y.; Zong, W.; Yan, J.; Liu, M. The correlation between the CLEC16A gene and genetic susceptibility to type 1 diabetes in Chinese children. Int. J. Endocrinol. 2012, 2012, 245-384.
54. Howson, J.M.; Rosinger, S.; Smyth, D.J.; Boehm, B.O.; Group, A-E.S.; Todd, J.A. Genetic analysis of adult-onset autoimmune diabetes. Diabetes 2011, 60, 2645-2653.
55. Yamashita, H.; Awata, T.; Kawasaki, E.; Ikegami, H.; Tanaka, S.; Maruyama, T.; Shimada, A.; Nakanishi, K.; Takahashi, K.; Kobayashi, T, et al. Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes. Diabetes/Metab. Res. Rev. 2011, 27, 844-848.
56. Mells, G.F.; Floyd, J.A.; Morley, K.I.; Cordell, H.J.; Franklin, C.S.; Shin, S.Y.; Heneghan, M.A.; Neuberger, J.M.; Donaldson, P.T.; Day, D.B, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 2011, 43, 329-332.
57. Chang, C.H.; Flavell, R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 1995, 181, 765-767.
58. Chang, C.H.; Guerder, S.; Hong, S.C.; van Ewijk, W.; Flavell, R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996, 4, 167-178.
59. Rasmussen, H.B.; Kelly, M.A.; Clausen, J. Genetic susceptibility to multiple sclerosis: Detection of polymorphic nucleotides and an intron in the 3' untranslated region of the major histocompatibility complex class II transactivator gene. Hum. Immunol. 2001, 62, 371-377.
60. Swanberg, M.; Lidman, O.; Padyukov, L.; Eriksson, P.; Akesson, E.; Jagodic, M.; Lobell, A.; Khademi, M.; Borjesson, O.; Lindgren, C.M, et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 2005, 37, 486-494.
61. Bronson, P.G.; Caillier, S.; Ramsay, P.P.; McCauley, J.L.; Zuvich, R.L.; De Jager, P.L.; Rioux, J.D.; Ivinson, A.J.; Compston, A.; Hafler, D.A, et al. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum. Mol. Genet. 2010, 19, 2331-2340.
62. Gyllenberg, A.; Asad, S.; Piehl, F.; Swanberg, M.; Padyukov, L.; Van Yserloo, B.; Rutledge, E.A.; McNeney, B.; Graham, J.; Orho-Melander, M, et al. Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes. Genes Immun. 2012, 13, 632-640.
63. Eike, M.C.; Skinningsrud, B.; Ronninger, M.; Stormyr, A.; Kvien, T.K.; Joner, G.; Njolstad, P.R.; Forre, O.; Flato, B.; Alfredsson, L, et al. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. Genes Immun. 2012, 13, 431-436.
64. Bronson, P.G.; Goldstein, B.A.; Ramsay, P.P.; Beckman, K.B.; Noble, J.A.; Lane, J.A.; Seldin, M.F.; Kelly, J.A.; Harley, J.B.; Moser, K.L, et al. The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus. Genes Immun. 2011, 12, 667-671.
65. Ghaderi, M.; Gambelunghe, G.; Tortoioli, C.; Brozzetti, A.; Jatta, K.; Gharizadeh, B.; de Bellis, A.; Pecori Giraldi, F.; Terzolo, M.; Betterle, C, et al. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 2006, 91, 4107-4111.
66. Vandenbroeck, K.; Alvarez, J.; Swaminathan, B.; Alloza, I.; Matesanz, F.; Urcelay, E.; Comabella, M.; Alcina, A.; Fedetz, M.; Ortiz, M.A, et al. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun. 2012, 13, 21-28.
67. Fenner, J.E.; Starr, R.; Cornish, A.L.; Zhang, J.G.; Metcalf, D.; Schreiber, R.D.; Sheehan, K.; Hilton, D.J.; Alexander, W.S.; Hertzog, P.J. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 2006, 7, 33-39.
68. Zuvich, R.L.; McCauley, J.L.; Oksenberg, J.R.; Sawcer, S.J.; De Jager, P.L.; International Multiple Sclerosis Genetics, C.; Aubin, C.; Cross, A.H.; Piccio, L.; Aggarwal, N.T, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum. Genet. 2010, 127, 525-535.
69. International Multiple Sclerosis Genetics Consortium. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum. Mol. Genet. 2010, 19, 953-962.
70. Leikfoss, I.S.; Mero, I.L.; Dahle, M.K.; Lie, B.A.; Harbo, H.F.; Spurkland, A.; Berge, T. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus. Genes Immun. 2013, 14, 62-66.
71. Davison, L.J.; Wallace, C.; Cooper, J.D.; Cope, N.F.; Wilson, N.K.; Smyth, D.J.; Howson, J.M.; Saleh, N.; Al-Jeffery, A.; Angus, K.L, et al. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum. Mol. Genet. 2012, 21, 322-333.
72. Nica, A.C.; Montgomery, S.B.; Dimas, A.S.; Stranger, B.E.; Beazley, C.; Barroso, I.; Dermitzakis, E.T. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 2010, 6, e1000895.
73. Edgar, A.J.; Birks, E.J.; Yacoub, M.H.; Polak, J.M. Cloning of dexamethasone-induced transcript: A novel glucocorticoid-induced gene that is upregulated in emphysema. Am. J. Respir. Cell Mol. Biol. 2001, 25, 119-124.
74. Cortes, A.; Brown, M.A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 2011, 13, 101.
75. Eyre, S.; Bowes, J.; Diogo, D.; Lee, A.; Barton, A.; Martin, P.; Zhernakova, A.; Stahl, E.; Viatte, S.; McAllister, K, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 2012, 44, 1336-1340.
76. Cooper, J.D.; Simmonds, M.J.; Walker, N.M.; Burren, O.; Brand, O.J.; Guo, H.; Wallace, C.; Stevens, H.; Coleman, G.; Wellcome Trust Case Control Consortium; et al. Seven newly identified loci for autoimmune thyroid disease. Hum. Mol. Genet. 2012, 21, 5202-5208.
77. Yoshimura, A.; Suzuki, M.; Sakaguchi, R.; Hanada, T.; Yasukawa, H. SOCS, Inflammation, and autoimmunity. Front. Immunol. 2012, 3, 20.
78. Friese, M.A.; Jones, E.Y.; Fugger, L. MHC II molecules in inflammatory diseases: Interplay of qualities and quantities. Trends Immunol. 2005, 26, 559-561.
79. UCSC Genome Bioinformatics. Available online: http://genome.ucsc.edu (accessed on 15 December 2012).
80. Nagase, T.; Ishikawa, K.; Nakajima, D.; Ohira, M.; Seki, N.; Miyajima, N.; Tanaka, A.; Kotani, H.; Nomura, N.; Ohara, O. Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res. 1997, 4, 141-150.
81. Wu, X.; Li, J.; Chen, C.; Yan, Y.; Jiang, S.; Wu, X.; Shao, B.; Xu, J.; Kang, L.; Huang, Y, et al. Involvement of CLEC16A in activation of astrocytes after LPS treated. Neurochem. Res. 2012, 37, 5-14.
82. Wang, G.S.; Cooper, T.A. Splicing in disease: Disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 2007, 8, 749-761.
83. Bates, E.E.; Fournier, N.; Garcia, E.; Valladeau, J.; Durand, I.; Pin, J.J.; Zurawski, S.M.; Patel, S.; Abrams, J.S.; Lebecque, S, et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 1999, 163, 1973-1983.
84. Fujikado, N.; Saijo, S.; Yonezawa, T.; Shimamori, K.; Ishii, A.; Sugai, S.; Kotaki, H.; Sudo, K.; Nose, M.; Iwakura, Y. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 2008, 14, 176-180.
85. McGreal, E.P.; Martinez-Pomares, L.; Gordon, S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol. Immunol. 2004, 41, 1109-1121.
86. Prosite-Database of Protein Domains, Families and Functional Sites. Available online: http://prosite.expasy.org (accessed on 15 December 2012).
87. Zelensky, A.N.; Gready, J.E. The C-type lectin-like domain superfamily. FEBS J. 2005, 272, 6179-6217.
88. Cummings, R.D.; McEver, R.P. C-Type Lectins. In Essentials of Glycobiology, 2nd ed.; Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., Eds.; Cold Spring Harbor: News York, NY, USA, 2009.
89. Kingeter, L.M.; Lin, X. C-type lectin receptor-induced NF-kappaB activation in innate immune and inflammatory responses. Cell. Mol. Immunol. 2012, 9, 105-112.
90. Dinkel, H.; Chica, C.; Via, A.; Gould, C.M.; Jensen, L.J.; Gibson, T.J.; Diella, F. Phospho.ELM: A database of phosphorylation sites-Update 2011. Nucleic Acids Res. 2011, 39, D261-D267.
91. The Eukaryotic Linear Motif Resource for Functional Sites in Proteins. Available online: http://elm.eu.org(accessed on 15 December 2012).
92. Marchler-Bauer, A.; Anderson, J.B.; Chitsaz, F.; Derbyshire, M.K.; DeWeese-Scott, C.; Fong, J.H.; Geer, L.Y.; Geer, R.C.; Gonzales, N.R.; Gwadz, M, et al. CDD: Specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 2009, 37, D205-D210.
93. Swiss EMBnet Node Server. Available online http://www.ch.embnet.org (accessed on 15 December 2012).
94. National Center for Biotechnology Information. Available online: http://www.ncbi.nlm.nih.gov (accessed on 15 December 2012).
95. UniProt-A resource of Protein Sequence and Functional Information. Available online: www.uniprot.org (accessed on 15 December 2012).
96. Kim, S.; Wairkar, Y.P.; Daniels, R.W.; DiAntonio, A. The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation. J. Cell Biol. 2010, 188, 717-734.
97. Kim, S.; Diantonio, A. A role for the membrane Golgi protein Ema in autophagy. Autophagy 2012, 8, 1269-1270.
98. Thompson, J.D.; Gibson, T.J.; Higgins, D.G. Multiple sequence alignment using ClustalW and ClustalX. Curr. Prot. Bioinform. 2002, 2.3.1-2.3.22.
99. Seto, E.S.; Bellen, H.J.; Lloyd, T.E. When cell biology meets development: Endocytic regulation of signaling pathways. Genes Dev. 2002, 16, 1314-1336.
100. German, C.L.; Sauer, B.M.; Howe, C.L. The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures. Exp. Cell Res. 2011, 317, 1955-1969.
101. Payelle-Brogard, B.; Pellegrini, S. Biochemical monitoring of the early endocytic traffic of the type I interferon receptor. J. Interferon Cytokine Res. 2010, 30, 89-98.
102. Westlake, C.J.; Junutula, J.R.; Simon, G.C.; Pilli, M.; Prekeris, R.; Scheller, R.H.; Jackson, P.K.; Eldridge, A.G. Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc. Natl. Acad. Sci. USA 2007, 104, 1236-1241.
103. Hehnly, H.; Chen, C.T.; Powers, C.M.; Liu, H.L.; Doxsey, S. The centrosome regulates the rab11-dependent recycling endosome pathway at appendages of the mother centriole. Curr. Biol. 2012, 22, 1944-1950.
104. Pierdominici, M.; Vomero, M.; Barbati, C.; Colasanti, T.; Maselli, A.; Vacirca, D.; Giovannetti, A.; Malorni, W.; Ortona, E. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J. 2012, 26, 1400-1412.
105. Zhou, X.J.; Lu, X.L.; Lv, J.C.; Yang, H.Z.; Qin, L.X.; Zhao, M.H.; Su, Y.; Li, Z.G.; Zhang, H. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann. Rheumatic Dis. 2011, 70, 1330-1337.
106. Henckaerts, L.; Cleynen, I.; Brinar, M.; John, J.M.; van Steen, K.; Rutgeerts, P.; Vermeire, S. Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease. Inflamm. Bowel Dis. 2011, 17, 1392-1397.
107. Shin, D.M.; Yuk, J.M.; Lee, H.M.; Lee, S.H.; Son, J.W.; Harding, C.V.; Kim, J.M.; Modlin, R.L.; Jo, E.K. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell. Microbiol. 2010, 12, 1648-1665.
108. Portillo, J.A.; Okenka, G.; Reed, E.; Subauste, A.; van Grol, J.; Gentil, K.; Komatsu, M.; Tanaka, K.; Landreth, G.; Levine, B, et al. The CD40-autophagy pathway is needed for host protection despite IFN-Gamma-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 2010, 5, e14472.
109. Nair, A.; Frederick, T.J.; Miller, S.D. Astrocytes in multiple sclerosis: A product of their environment. Cell. Mol. Life Sci. 2008, 65, 2702-2720.
110. Cookson, W.; Liang, L.; Abecasis, G.; Moffatt, M.; Lathrop, M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 2009, 10, 184-194.
111. Nicolae, D.L.; Gamazon, E.; Zhang, W.; Duan, S.; Dolan, M.E.; Cox, N.J. Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genet. 2010, 6, e1000888.
112. Consortium, E.P.; Dunham, I.; Kundaje, A.; Aldred, S.F.; Collins, P.J.; Davis, C.A.; Doyle, F.; Epstein, C.B.; Frietze, S.; Harrow, J, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57-74.
113. Schaub, M.A.; Boyle, A.P.; Kundaje, A.; Batzoglou, S.; Snyder, M. Linking disease associations with regulatory information in the human genome. Genome Res. 2012, 22, 1748-1759.
114. Maurano, M.T.; Humbert, R.; Rynes, E.; Thurman, R.E.; Haugen, E.; Wang, H.; Reynolds, A.P.; Sandstrom, R.; Qu, H.; Brody, J, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337, 1190-1195.